| Tumor imaging using a picomolar affinity HER2 binding affibody molecule A Orlova, M Magnusson, TLJ Eriksson, M Nilsson, B Larsson, ... Cancer research 66 (8), 4339-4348, 2006 | 670 | 2006 |
| Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In-or 68Ga-labeled affibody molecules RP Baum, V Prasad, D Müller, C Schuchardt, A Orlova, A Wennborg, ... Journal of nuclear medicine 51 (6), 892-897, 2010 | 363 | 2010 |
| Radionuclide Therapy of HER2-Positive Microxenografts Using a 177Lu-Labeled HER2-Specific Affibody Molecule V Tolmachev, A Orlova, R Pehrson, J Galli, B Baastrup, K Andersson, ... Cancer research 67 (6), 2773-2782, 2007 | 281 | 2007 |
| Measuring HER2-receptor expression in metastatic breast cancer using [68Ga] ABY-025 Affibody PET/CT J Sörensen, I Velikyan, D Sandberg, A Wennborg, J Feldwisch, ... Theranostics 6 (2), 262, 2016 | 271 | 2016 |
| Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors A Orlova, V Tolmachev, R Pehrson, M Lindborg, T Tran, M Sandstrom, ... Cancer research 67 (5), 2178-2186, 2007 | 243 | 2007 |
| Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule M Friedman, A Orlova, E Johansson, TLJ Eriksson, I Höidén-Guthenberg, ... Journal of molecular biology 376 (5), 1388-1402, 2008 | 206 | 2008 |
| Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy V Tolmachev, A Orlova, FY Nilsson, J Feldwisch, A Wennborg, ... Expert opinion on biological therapy 7 (4), 555-568, 2007 | 174 | 2007 |
| On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model A Orlova, H Wållberg, S Stone-Elander, V Tolmachev Journal of Nuclear Medicine 50 (3), 417-425, 2009 | 160 | 2009 |
| Pharmacologic inhibition of STAT5 in acute myeloid leukemia B Wingelhofer, B Maurer, EC Heyes, AA Cumaraswamy, A Berger-Becvar, ... Leukemia 32 (5), 1135-1146, 2018 | 151 | 2018 |
| Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry V Tolmachev, M Friedman, M Sandström, TLJ Eriksson, D Rosik, M Hodik, ... Journal of Nuclear Medicine 50 (2), 274-283, 2009 | 148 | 2009 |
| Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected … V Tolmachev, D Rosik, H Wållberg, A Sjöberg, M Sandström, M Hansson, ... European journal of nuclear medicine and molecular imaging 37, 613-622, 2010 | 147 | 2010 |
| Slow Internalization of Anti-HER2 Synthetic Affibody Monomer 111In-DOTA-ZHER2:342-pep2 : Implications for Development of Labeled Tracers H Wållberg, A Orlova Cancer biotherapy & radiopharmaceuticals 23 (4), 435-442, 2008 | 145 | 2008 |
| Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2: 2395, with C-terminally engineered cysteine S Ahlgren, H Wållberg, TA Tran, C Widström, M Hjertman, L Abrahmsén, ... Journal of Nuclear Medicine 50 (5), 781-789, 2009 | 143 | 2009 |
| 111In-benzyl-DTPA–ZHER2: 342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors V Tolmachev, FY Nilsson, C Widström, K Andersson, D Rosik, L Gedda, ... Journal of Nuclear Medicine 47 (5), 846-853, 2006 | 143 | 2006 |
| 99mTc-maEEE-ZHER2:342, an Affibody Molecule-Based Tracer for the Detection of HER2 Expression in Malignant Tumors T Tran, T Engfeldt, A Orlova, M Sandström, J Feldwisch, L Abrahmsén, ... Bioconjugate chemistry 18 (6), 1956-1964, 2007 | 139 | 2007 |
| Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules S Ahlgren, A Orlova, D Rosik, M Sandström, A Sjöberg, B Baastrup, ... Bioconjugate chemistry 19 (1), 235-243, 2008 | 137 | 2008 |
| Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors A Orlova, FY Nilsson, M Wikman, C Widström, S Ståhl, J Carlsson, ... Journal of Nuclear Medicine 47 (3), 512-519, 2006 | 136 | 2006 |
| Same-day imaging using small proteins: clinical experience and translational prospects in oncology A Krasniqi, M D’Huyvetter, N Devoogdt, FY Frejd, J Sörensen, A Orlova, ... Journal of Nuclear Medicine 59 (6), 885-891, 2018 | 133 | 2018 |
| Biodistribution and radiation dosimetry of the anti-HER2 affibody molecule 68Ga-ABY-025 in breast cancer patients M Sandström, K Lindskog, I Velikyan, A Wennborg, J Feldwisch, ... Journal of Nuclear Medicine 57 (6), 867-871, 2016 | 128 | 2016 |
| Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold S Ahlgren, A Orlova, H Wållberg, M Hansson, M Sandström, R Lewsley, ... Journal of nuclear medicine 51 (7), 1131-1138, 2010 | 122 | 2010 |
